Cancer news

Latest news, press releases and blog posts from Cancer Research UK.


Scientists uncover virus's role in skin cancer

Researchers are a step closer to understanding how the HPV virus1 might play a role in the development of some cases of non-melanoma skin cancer (NMSC).

Non-melanoma skin cancer linked with increased risk for other cancers

People who have previously had non-melanoma skin cancer appear to face a higher risk of other cancers, US scientists have found.

New technology adds weight to viral cancer link

New research from the US has provided more evidence that certain strains of Human papillomavirus (HPV) may be linked to a form of non-melanoma skin cancer.

"Light bandage" to treat skin cancer say researchers

Scottish researchers have developed a new light-emitting device, similar to a common sticking plaster, which could be used to treat non-melanoma skin cancer.

NICE updates skin cancer guidance

The National Institute for Health and Clinical Excellence has updated its recommendations on the diagnosis and of 'low risk' basal cell carcinomas.

Teenagers get sunburnt on purpose

More than a quarter of teenagers will get sunburnt on purpose this summer in the belief that they will ultimately get a suntan, a survey has found.

Scientists uncover how cancer stem cells are regulated in common skin cancer

Belgian scientists have discovered that a molecule already targeted by several cancer therapies may play a crucial role in a common form of skin cancer.

Study links sunbeds to most common forms of skin cancer

As well as increasing the risk of melanoma skin cancer - the most serious form of the disease - sunbed users are also at increased risk of developing the much more common...

Contact allergies 'may be associated with reduced risk of some cancers'

People with contact allergies to common metals and chemicals may be less likely to develop certain types of cancer, according to a study by scientists.

New drug approved for advanced non-melanoma skin cancer

Patients with a form of skin cancer that's spread or come back after treatment could benefit from a new drug that has been approved for use in the UK.